Global Knee Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 07-Aug-2020
No. of pages: 94
Inquire Before Buying

Knee Osteoarthritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Knee Osteoarthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Non-surgical Treatment

- Surgical Treatment

Market segment by Application, split into

- Hospitals

- Ambulatory Surgical Centers

- Specialty Clinics

- Others

Based on regional and country-level analysis, the Knee Osteoarthritis Treatment market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Knee Osteoarthritis Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Bioventus

- AVM Biotechnology

- Anika Therapeutics

- Flexion Therapeutics

- OrthoTrophix

- Sanofi

- Horizon Therapeutics

- Johnson and Johnson

- GlaxoSmithKline

- Bayer

- Abbott

- Pfizer

Global Knee Osteoarthritis Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Knee Osteoarthritis Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Knee Osteoarthritis Treatment Market Perspective (2015-2026)
2.2 Global Knee Osteoarthritis Treatment Growth Trends by Regions
2.2.1 Knee Osteoarthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Knee Osteoarthritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knee Osteoarthritis Treatment Players by Market Size
3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Knee Osteoarthritis Treatment Revenue
3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio
3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2019
3.5 Key Players Knee Osteoarthritis Treatment Area Served
3.6 Key Players Knee Osteoarthritis Treatment Product Solution and Service
3.7 Date of Enter into Knee Osteoarthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Knee Osteoarthritis Treatment Breakdown Data by Type (2015-2026)
4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2021-2026)
5 Knee Osteoarthritis Treatment Breakdown Data by Application (2015-2026)
5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2015-2020)
5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Knee Osteoarthritis Treatment Market Size (2015-2026)
6.2 North America Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
6.3 North America Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Knee Osteoarthritis Treatment Market Size (2015-2026)
7.2 Europe Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
7.3 Europe Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Knee Osteoarthritis Treatment Market Size (2015-2026)
8.2 China Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
8.3 China Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
8.4 China Knee Osteoarthritis Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Knee Osteoarthritis Treatment Market Size (2015-2026)
9.2 Japan Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
9.3 Japan Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
9.4 Japan Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Knee Osteoarthritis Treatment Market Size (2015-2026)
10.2 Southeast Asia Knee Osteoarthritis Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Knee Osteoarthritis Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Knee Osteoarthritis Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Bioventus
11.1.1 Bioventus Company Details
11.1.2 Bioventus Business Overview
11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction
11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2015-2020))
11.1.5 Bioventus Recent Development
11.2 AVM Biotechnology
11.2.1 AVM Biotechnology Company Details
11.2.2 AVM Biotechnology Business Overview
11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction
11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.2.5 AVM Biotechnology Recent Development
11.3 Anika Therapeutics
11.3.1 Anika Therapeutics Company Details
11.3.2 Anika Therapeutics Business Overview
11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction
11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.3.5 Anika Therapeutics Recent Development
11.4 Flexion Therapeutics
11.4.1 Flexion Therapeutics Company Details
11.4.2 Flexion Therapeutics Business Overview
11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction
11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.4.5 Flexion Therapeutics Recent Development
11.5 OrthoTrophix
11.5.1 OrthoTrophix Company Details
11.5.2 OrthoTrophix Business Overview
11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction
11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.5.5 OrthoTrophix Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction
11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.6.5 Sanofi Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Details
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.7.5 Horizon Therapeutics Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction
11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Knee Osteoarthritis Treatment Introduction
11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
11.10.5 Bayer Recent Development
11.11 Abbott
10.11.1 Abbott Company Details
10.11.2 Abbott Business Overview
10.11.3 Abbott Knee Osteoarthritis Treatment Introduction
10.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
10.11.5 Abbott Recent Development
11.12 Pfizer
10.12.1 Pfizer Company Details
10.12.2 Pfizer Business Overview
10.12.3 Pfizer Knee Osteoarthritis Treatment Introduction
10.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
10.12.5 Pfizer Recent Development
11.13 Eli Lilly
10.13.1 Eli Lilly Company Details
10.13.2 Eli Lilly Business Overview
10.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction
10.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2015-2020)
10.13.5 Eli Lilly Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Non-surgical Treatment
Table 4. Key Players of Surgical Treatment
Table 5. Global Knee Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Knee Osteoarthritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Knee Osteoarthritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Knee Osteoarthritis Treatment Market Share by Regions (2015-2020)
Table 9. Global Knee Osteoarthritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Knee Osteoarthritis Treatment Market Share by Regions (2021-2026)
Table 11. Knee Osteoarthritis Treatment Market Market Trends
Table 12. Knee Osteoarthritis Treatment Market Drivers
Table 13. Knee Osteoarthritis Treatment Market Challenges
Table 14. Knee Osteoarthritis Treatment Market Restraints
Table 15. Global Knee Osteoarthritis Treatment Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Knee Osteoarthritis Treatment Market Share by Players (2015-2020)
Table 17. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Knee Osteoarthritis Treatment as of 2019)
Table 18. Global Knee Osteoarthritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Knee Osteoarthritis Treatment Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Knee Osteoarthritis Treatment Market Size Share by Type (2015-2020)
Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2021-2026)
Table 25. Global Knee Osteoarthritis Treatment Market Size Share by Application (2015-2020)
Table 26. Global Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Knee Osteoarthritis Treatment Market Size Share by Application (2021-2026)
Table 28. North America Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Knee Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 30. North America Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Knee Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 32. North America Knee Osteoarthritis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Knee Osteoarthritis Treatment Market Share by Country (2015-2020)
Table 34. Europe Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Knee Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 36. Europe Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Knee Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 38. Europe Knee Osteoarthritis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Knee Osteoarthritis Treatment Market Share by Country (2015-2020)
Table 40. China Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 41. China Knee Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 42. China Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 43. China Knee Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 44. China Knee Osteoarthritis Treatment Market Size by Region (US$ Million) (2015-2020)
Table 45. China Knee Osteoarthritis Treatment Market Share by Region (2015-2020)
Table 46. Japan Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Knee Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 48. Japan Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Knee Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 50. Japan Knee Osteoarthritis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Knee Osteoarthritis Treatment Market Share by Country (2015-2020)
Table 52. Southeast Asia Knee Osteoarthritis Treatment Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Knee Osteoarthritis Treatment Market Share by Type (2015-2020)
Table 54. Southeast Asia Knee Osteoarthritis Treatment Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Knee Osteoarthritis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Knee Osteoarthritis Treatment Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Knee Osteoarthritis Treatment Market Share by Country (2015-2020)
Table 58. Bioventus Company Details
Table 59. Bioventus Business Overview
Table 60. Bioventus Product
Table 61. Bioventus Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 62. Bioventus Recent Development
Table 63. AVM Biotechnology Company Details
Table 64. AVM Biotechnology Business Overview
Table 65. AVM Biotechnology Product
Table 66. AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 67. AVM Biotechnology Recent Development
Table 68. Anika Therapeutics Company Details
Table 69. Anika Therapeutics Business Overview
Table 70. Anika Therapeutics Product
Table 71. Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 72. Anika Therapeutics Recent Development
Table 73. Flexion Therapeutics Company Details
Table 74. Flexion Therapeutics Business Overview
Table 75. Flexion Therapeutics Product
Table 76. Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 77. Flexion Therapeutics Recent Development
Table 78. OrthoTrophix Company Details
Table 79. OrthoTrophix Business Overview
Table 80. OrthoTrophix Product
Table 81. OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 82. OrthoTrophix Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Product
Table 86. Sanofi Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Horizon Therapeutics Company Details
Table 89. Horizon Therapeutics Business Overview
Table 90. Horizon Therapeutics Product
Table 91. Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 92. Horizon Therapeutics Recent Development
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Product
Table 95. Johnson and Johnson Company Details
Table 96. Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 97. Johnson and Johnson Recent Development
Table 98. GlaxoSmithKline Company Details
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 102. GlaxoSmithKline Recent Development
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Product
Table 106. Bayer Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 107. Bayer Recent Development
Table 108. Abbott Company Details
Table 109. Abbott Business Overview
Table 110. Abbott Product
Table 111. Abbott Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 112. Abbott Recent Development
Table 113. Pfizer Company Details
Table 114. Pfizer Business Overview
Table 115. Pfizer Product
Table 116. Pfizer Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 117. Pfizer Recent Development
Table 118. Eli Lilly Company Details
Table 119. Eli Lilly Business Overview
Table 120. Eli Lilly Product
Table 121. Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2015-2020) (US$ Million)
Table 122. Eli Lilly Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Knee Osteoarthritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Non-surgical Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Global Knee Osteoarthritis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Knee Osteoarthritis Treatment Report Years Considered
Figure 10. Global Knee Osteoarthritis Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Knee Osteoarthritis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Knee Osteoarthritis Treatment Market Share by Regions (2021-2026)
Figure 13. Global Knee Osteoarthritis Treatment Market Share by Players in 2019
Figure 14. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Knee Osteoarthritis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2019
Figure 16. North America Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 44. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 45. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 46. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 47. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 48. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 49. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 50. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 52. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 53. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 54. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 55. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs